295 related articles for article (PubMed ID: 14717387)
1. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: what we know and current controversies.
Moser DK; Biddle MJ
Crit Care Nurs Clin North Am; 2003 Dec; 15(4):423-37, vii-viii. PubMed ID: 14717387
[TBL] [Abstract][Full Text] [Related]
2. Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?
Pitt B
Curr Heart Fail Rep; 2009 Jun; 6(2):112-6. PubMed ID: 19486595
[TBL] [Abstract][Full Text] [Related]
3. Neurohumoral blockade in CHF management.
Willenbrock R; Philipp S; Mitrovic V; Dietz R
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1 Suppl 1():24-30. PubMed ID: 11967792
[TBL] [Abstract][Full Text] [Related]
4. Update on recent clinical trials in congestive heart failure.
Betkowski AS; Hauptman PJ
Curr Opin Cardiol; 2000 Jul; 15(4):293-303. PubMed ID: 11139094
[TBL] [Abstract][Full Text] [Related]
5. What constitutes optimal neurohumoral antagonism in chronic heart failure?
Tajik AA; Dickstein K
Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
[No Abstract] [Full Text] [Related]
6. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
7. Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials.
Hansen MR; Hróbjartsson A; Videbæk L; Ennis ZN; Pareek M; Paulsen NH; Broe M; Olesen M; Pottegård A; Damkier P; Hallas J
Am J Med; 2020 Jun; 133(6):e280-e289. PubMed ID: 32173347
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
Miller AB; Srivastava P
Cardiol Clin; 2001 May; 19(2):195-202, v. PubMed ID: 11407105
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin-aldosterone system inhibitors in heart failure.
Shearer F; Lang CC; Struthers AD
Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
[TBL] [Abstract][Full Text] [Related]
10. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs.
Hyman DA; Siebert VR; Birnbaum GD; Alam M; Birnbaum Y
Cardiovasc Drugs Ther; 2020 Apr; 34(2):215-221. PubMed ID: 32219664
[TBL] [Abstract][Full Text] [Related]
11. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
van Diepen S; Reynolds HR; Stebbins A; Lopes RD; Džavík V; Ruzyllo W; Geppert A; Widimsky P; Ohman EM; Parrillo JE; Dauerman HL; Baran DA; Hochman JS; Alexander JH
Crit Care Med; 2014 Feb; 42(2):281-8. PubMed ID: 23982033
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
Jorde UP
Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials?
Mielniczuk L; Stevenson LW
Curr Opin Cardiol; 2005 Jul; 20(4):250-5. PubMed ID: 15956818
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.
Beitelshees AL; Zineh I
Heart Fail Rev; 2010 May; 15(3):209-17. PubMed ID: 18351457
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blockers in congestive heart failure: evidence, concerns, and controversies.
Bhatia V; Bhatia R; Mathew B
Cardiol Rev; 2005; 13(6):297-303. PubMed ID: 16230887
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin antagonism in patients with heart failure: ACE inhibitors, angiotensin receptor antagonists or both?
Cruden NL; Newby DE
Am J Cardiovasc Drugs; 2004; 4(6):345-53. PubMed ID: 15554719
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure.
Hebert PR; Foody JM; Hennekens CH
Curr Vasc Pharmacol; 2003 Mar; 1(1):33-9. PubMed ID: 15320851
[TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin-aldosterone system and heart failure.
Sayer G; Bhat G
Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
[TBL] [Abstract][Full Text] [Related]
19. Targeting the renin-angiotensin-aldosterone system in heart failure.
Lang CC; Struthers AD
Nat Rev Cardiol; 2013 Mar; 10(3):125-34. PubMed ID: 23319100
[TBL] [Abstract][Full Text] [Related]
20. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
Cohn JN
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
